Loading clinical trials...
Loading clinical trials...
Central venous catheters are essential when administering treatment for hematological conditions. Many patients have a decreased platelet count which increases the risk for bleeding complications. Ba...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Thomas Kander
NCT06740929 · Heavy Menstrual Bleeding, Bleeding Disorder
NCT06721013 · Immune Thrombocytopenia (ITP)
NCT05454787 · Life Threatening Bleeding, Factor Xa Inhibitor
NCT06482333 · Postpolypectomy Bleeding
NCT06820515 · Hemophilia, Thrombosis, and more
Thomas Kander
Lund, Lunds Universitet
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions